Axiom Therapeutics LLC South Jordan, UT - 84095

Axiom Therapeutics LLC is categorized under Home Health Care Services in South Jordan, UT and active since 2004.

Axiom Therapeutics LLC was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6216100 by the NAICS.

If you are seeking more information, feel free to contact Eric Melde, President at the company’s single location by writing to 1682 West Reunion Avenue # 100, South Jordan, Utah UT 84095 or by phoning (801) 254-8581. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Axiom Therapeutics LLC
Contact Person: Eric Melde, President
Address: 1682 West Reunion Avenue # 100, South Jordan, Utah 84095
Phone Number: (801) 254-8581
Annual Revenue (USD): $100.000 to $499.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Home Health Care Services
SIC Code: 8082
NAICS Code: 6216100
Share This Business:

Axiom Therapeutics LLC was started in 2004 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Eric Melde, President for inquiries that concern Axiom Therapeutics LLC by calling the company number (801) 254-8581, as your correspondence is most welcome. Additionally, the physical location of the single location of Axiom Therapeutics LLC can be found at the coordinates 40.56928,-111.93826 as well as the street address 1682 West Reunion Avenue # 100 in South Jordan, Utah 84095.

For its online presence, you may visit Axiom Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.